SMALL LYMPHOCYTIC LYMPHOMA (SLL)
Clinical trials for SMALL LYMPHOCYTIC LYMPHOMA (SLL) explained in plain language.
Never miss a new study
Get alerted when new SMALL LYMPHOCYTIC LYMPHOMA (SLL) trials appear
Sign up with your email to follow new studies for SMALL LYMPHOCYTIC LYMPHOMA (SLL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial offers hope for patients with aggressive lymphoma that Won't quit
Disease control OngoingThis trial is testing a new drug called epcoritamab in people with B-cell lymphoma that has come back or stopped responding to standard treatments. The main goals are to find a safe and effective dose, understand the side effects, and see how well the drug works to control the ca…
Matched conditions: SMALL LYMPHOCYTIC LYMPHOMA (SLL)
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated Apr 02, 2026 03:41 UTC
-
Cancer treatment break: study tests stopping pills when disease disappears
Disease control OngoingThis study is testing whether people with chronic lymphocytic leukemia or small lymphocytic lymphoma can safely stop their venetoclax treatment when blood tests show no detectable cancer cells. Researchers will follow 81 patients who stop treatment to see if they remain cancer-fr…
Matched conditions: SMALL LYMPHOCYTIC LYMPHOMA (SLL)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC